Related Experiment Video
Updated: Aug 5, 2026

09:37
A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
[ACE gene I/D-polymorphism and hereditary predisposition to myocardial infarction]
Klinicheskaia Meditsina
|October 4, 2002
Summary
The ACE gene I/D polymorphism, specifically the DD genotype, is linked to a higher risk of myocardial infarction (MI) and its complications. This genetic marker may indicate a predisposition to developing MI.
Area of Science:
- Genetics
- Cardiology
- Molecular Biology
Context:
- Ischemic heart disease (IHD) encompasses various conditions, including acute myocardial infarction (MI) and postinfarction cardiosclerosis (PICS).
- Genetic factors play a role in the susceptibility and progression of cardiovascular diseases.
- The angiotensin-converting enzyme (ACE) gene I/D polymorphism is a well-studied genetic variation with potential implications in cardiovascular health.
Purpose:
- To investigate the association between the ACE gene I/D polymorphism and different forms of ischemic heart disease.
- To determine if specific genotypes or alleles of the ACE gene are more prevalent in patients with acute MI, stable effort angina, or PICS.
- To evaluate the potential of ACE gene polymorphism as a marker for MI risk and prognosis.
Summary:
- A significant association was found between the ACE gene I/D polymorphism and acute MI. The DD genotype occurred more frequently in MI patients (0.57) compared to controls (0.21), with a relative risk of 4.9.
- Allele D frequency was higher in acute MI patients (0.76) than in those with PICS (0.51), suggesting a potential role in disease severity or lethality.
- The DD genotype was also more frequent in patients with repeated MI and associated complications, indicating its role in adverse cardiovascular events.
Impact:
- The DD genotype of the ACE gene I/D polymorphism may serve as a marker for hereditary predisposition to MI.
- This finding could contribute to personalized risk assessment for MI and guide preventative strategies.
- Understanding the genetic basis of MI risk can lead to improved patient management and potentially reduced mortality and morbidity from cardiovascular disease.
Related Concept Videos
Genetic Lingo
Overview
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

